When should dopaminergic treatment be initiated in Parkinson's disease?

Dr. Ruth Schneider discusses with Dr. Sara Schaefer about the article she recently published in the Movement Disorders Clinical Practice that investigates the outcomes of early vs delayed start of dopaminergic medication in Parkinson's disease. Read the article